Special Issue "Marine Origin Agents for Therapy of Neglected Diseases"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 August 2018)
Dr. Luísa Custódio
Neglected Tropical Diseases (NTDs) are a group of 17 chronic and disabling infections affecting more than one billion people worldwide, primarily in extreme poor locations. The neglected designation comes from the reduced financial investment into research and development of new drugs, and because there is lack of public awareness in high-income countries. Because NTDs are linked to poor socioeconomic and hygienic conditions, they could also be termed diseases of neglected populations.
Notwithstanding the recent partial successes in the struggle to eliminate or even eradicate some NTDs, which have been achieved by WHO (World Health Organization) strategies of, for example, disease monitoring, vector control and preventive chemotherapy, the development of new, safe and affordable drugs remains an urgent need. In this context researchers have turned their attention to nature during the last decades, trying to identify compounds that can be used against NTDs. Marine organisms, including plants thriving in marine environments (halophytes) have been increasingly been recognised over the past few decades as a source of unique and novel biologically active natural products. This Special Issue, “Marine Origin Agents for Therapy of Neglected Diseases”, aims to highlight the importance to unlock the potential of marine organisms as sources of novel molecules to control neglected diseases. We welcome submissions from scientists and academics from across the world.
Dr. Luísa Custódio
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- marine natural products
- marine invertebrates
- marine microorganisms
- marine alga
- neglected tropical diseases
- drug discovery